Compare CRTO & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRTO | MLAB |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 817.5M | 719.9M |
| IPO Year | 2013 | 1995 |
| Metric | CRTO | MLAB |
|---|---|---|
| Price | $18.08 | $140.12 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $18.85 | N/A |
| AVG Volume (30 Days) | ★ 383.3K | 85.1K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 0.47% |
| EPS Growth | 38.95 | ★ 436.11 |
| EPS | 0.49 | ★ 1.25 |
| Revenue | ★ $2,296,692,000.00 | N/A |
| Revenue This Year | N/A | $2.30 |
| Revenue Next Year | $1.43 | $4.41 |
| P/E Ratio | ★ $35.57 | $108.67 |
| Revenue Growth | ★ 27.65 | N/A |
| 52 Week Low | $13.95 | $69.51 |
| 52 Week High | $25.29 | $144.35 |
| Indicator | CRTO | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 72.12 | 61.27 |
| Support Level | $16.42 | $119.77 |
| Resistance Level | $18.66 | $144.35 |
| Average True Range (ATR) | 0.81 | 6.27 |
| MACD | 0.40 | 1.42 |
| Stochastic Oscillator | 95.36 | 87.63 |
Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.